Schunkert H, Tang S S, Litwin S E, Diamant D, Riegger G, Dzau V J, Ingelfinger J R
Department of Internal Medicine II, University of Regensburg, Germany.
Cardiovasc Res. 1993 May;27(5):731-5. doi: 10.1093/cvr/27.5.731.
Activation of the intrarenal renin-angiotensin system may contribute to the pathophysiology of heart failure by accelerating the generation of angiotensin II at local sites within the kidneys. Activation of the local intrarenal renin-angiotensin system occurs in rats and with mild heart failure. The aim of the present study was to examine components of the circulating as well as the intrarenal renin-angiotensin system in rats with severe heart failure.
Six weeks after experimental myocardial infarction (heart failure, HF; n = 8) or sham operation (control, C; n = 6), haemodynamics and the circulating and intrarenal components of the renin-angiotensin system were studied.
HF rats were characterised by large infarctions (scar tissue > 40% of the left ventricular circumference). In comparison to sham operated controls, large myocardial infarctions resulted in severe heart failure with decreased systolic [108(SEM 3) mm Hg v 132(3) in C; p < 0.001] and diastolic arterial blood pressure [83(3) mm Hg v 95(2) in C; p < 0.05], decreased left ventricular systolic pressure [109(3) mm Hg v 132(3) in C; p < 0.005] and increased left ventricular end diastolic pressure [27(2) mm Hg v 5(1) in C; p < 0.0001]. In rats with severe heart failure, the circulating renin-angiotensin system was activated, with an increase in plasma renin activity (3.5-fold, p < 0.05) and plasma angiotensin II concentration (threefold, p < 0.01). In parallel, the intrarenal renin-angiotensin system was activated in severe heart failure. Increases occurred in renal renin mRNA level (1.7-fold, p < 0.01), renal angiotensinogen mRNA level (1.8-fold, p < 0.05), and renal angiotensin II concentration (twofold, p < 0.05) compared to C. Intrarenal angiotensin II concentrations exceeded plasma levels by a factor of 50 and were positively correlated with renal angiotensinogen mRNA levels (r = 0.874, p < 0.001), suggesting that local synthesis is the major source of angiotensin II found in the kidney.
The intrarenal renin-angiotensin system may be selectively activated in mild heart failure, while both circulating and intrarenal renin-angiotensin systems are induced as the extent of left ventricular function worsens.
肾内肾素 - 血管紧张素系统的激活可能通过加速肾脏局部位点血管紧张素II的生成,从而促进心力衰竭的病理生理过程。局部肾内肾素 - 血管紧张素系统在大鼠及轻度心力衰竭时被激活。本研究的目的是检测重度心力衰竭大鼠循环及肾内肾素 - 血管紧张素系统的组成成分。
在实验性心肌梗死6周后(心力衰竭,HF;n = 8)或假手术(对照组,C;n = 6),研究血流动力学以及肾素 - 血管紧张素系统的循环和肾内组成成分。
HF大鼠的特征为大面积梗死(瘢痕组织>左心室周长的40%)。与假手术对照组相比,大面积心肌梗死导致严重心力衰竭,收缩压降低[C组为132(3) mmHg,HF组为108(SEM 3) mmHg;p < 0.001],舒张压降低[C组为95(2) mmHg,HF组为83(3) mmHg;p < 0.05],左心室收缩压降低[C组为132(3) mmHg,HF组为109(3) mmHg;p < 0.005],左心室舒张末期压力升高[C组为5(1) mmHg,HF组为27(2) mmHg;p < 0.0001]。在重度心力衰竭大鼠中,循环肾素 - 血管紧张素系统被激活,血浆肾素活性增加(3.5倍,p < 0.05),血浆血管紧张素II浓度增加(3倍,p < 0.01)。同时,重度心力衰竭时肾内肾素 - 血管紧张素系统也被激活。与C组相比,肾素mRNA水平增加(1.7倍,p < 0.01),血管紧张素原mRNA水平增加(1.8倍,p < 0.05),肾血管紧张素II浓度增加(2倍,p < 0.05)。肾内血管紧张素II浓度超过血浆水平50倍,并与肾血管紧张素原mRNA水平呈正相关(r = 0.874,p < 0.001),提示局部合成是肾脏中血管紧张素II的主要来源。
肾内肾素 - 血管紧张素系统可能在轻度心力衰竭时被选择性激活,而随着左心室功能恶化的程度增加,循环及肾内肾素 - 血管紧张素系统均被诱导激活。